James P. Allison - 2018 Nobel Prize Winner
The 2018 Nobel Prize in Physiology and Medicine was awarded to James P. Allison for his work in tumor immunology. In 1977, Allison found evidence that leukocytes, also known as white blood cells, the key player of the innate immune response, were prevented from interacting with cancer cells due to the cancer cells having additional proteins. His work in later years investigated the factors that prevented the immune system from working against cancer cells. He was one of the first to isolate the T cell antigen receptor complex protein. He showed that cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a protein receptor in T cells that downregulates the immune response. Cancer has the ability to induce upregulation of this protein, giving the tumor the ability to avoid inducing immune responses. Allison showed that antibody blockade of CTLA-4 can lead to enhanced tumor immune response. This concept lead to the creation of Ipilimumab, a monoclonal antibody that interacts with CTLA-4.
Recent comments